Recent research highlights a novel nanodrug delivery system using microneedles to target COX2(+) endothelial cells, aiming to reduce glycocalyx degradation in psoriasis. This innovative approach could enhance treatment efficacy for patients suffering from this chronic inflammatory skin condition.
inflammation triggered nanodrug delivery microneedles targeting pathogenic cox2 endothelial cell mediated glycocalyx degradation to ameliorate psoriasis
Original title: “Inflammation-triggered nanodrug delivery microneedles targeting pathogenic COX2(+) endothelial cell-mediated glycocalyx degradation to ameliorate psoriasis.”